Does EMICIZUMAB-KXWH Cause Off label use? 542 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 542 reports of Off label use have been filed in association with EMICIZUMAB-KXWH. This represents 5.8% of all adverse event reports for EMICIZUMAB-KXWH.
542
Reports of Off label use with EMICIZUMAB-KXWH
5.8%
of all EMICIZUMAB-KXWH reports
22
Deaths
54
Hospitalizations
How Dangerous Is Off label use From EMICIZUMAB-KXWH?
Of the 542 reports, 22 (4.1%) resulted in death, 54 (10.0%) required hospitalization, and 4 (0.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMICIZUMAB-KXWH. However, 542 reports have been filed with the FAERS database.
What Other Side Effects Does EMICIZUMAB-KXWH Cause?
Haemorrhage (3,612)
No adverse event (654)
Haemarthrosis (487)
Fall (484)
Arthralgia (385)
Contusion (321)
Epistaxis (313)
Pain (260)
Head injury (248)
Muscle haemorrhage (222)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EMICIZUMAB-KXWH Alternatives Have Lower Off label use Risk?
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\LINAGLIPTIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\METFORMIN
EMICIZUMAB-KXWH vs EMSAM